FDA’s AI Launch, Medicare’s Tech Modernization, and New Health IT Coordinator

⁢ ⁤Updated June 04, 2025

Thomas Keane has been named Assistant Secretary for Technology Policy and national Coordinator for Health Information Technology, sources say.Keane, a‍ radiologist and former ⁢ONC advisor, assumes the role amid reorganization at the Department of Health and Human Services (HHS).

The Food and Drug Administration (FDA) has‍ initiated a broad rollout of Elsa, an agency-wide generative AI tool designed to⁣ enhance staff efficiency. The rollout follows news reports detailing the tool’s growth and employee sentiment regarding its​ implementation.

Meanwhile,the Centers for medicare & Medicaid Services (CMS) is advancing an ambitious tech modernization agenda,spearheaded by Amy Gleason and Arda Kara.CMS aims⁣ to demonstrate tangible progress in 2025,​ focusing on reengineering claims systems,‌ launching an AI lab, and consolidating data repositories.

According to budget documents, CMS plans ​to leverage automation and AI to transform claims processing, enhance payment integrity, and improve data sharing across the healthcare ecosystem.

In other news, Anne Wojcicki, founder of 23andMe,⁣ is seeking to reopen the company’s ⁣auction with the backing of‍ a Fortune 500 ⁢corporation. This development follows Regeneron’s earlier declaration to acquire 23andMe ⁤out of bankruptcy.

Hims & ⁤Hers Health has announced an agreement to acquire Wonders, a‌ European digital health company, expanding its ​reach into the United Kingdom, Germany, France, and Ireland.

Clairity, Inc. received FDA authorization‍ for Clairity ‍Breast, an image-based platform predicting five-year breast cancer risk from mammograms.

viz.ai is partnering with Novartis to develop AI-powered workflows for ‌prostate and breast cancer.

IBM and roche are⁣ collaborating to provide glucose ⁣predictions for users ⁢of Roche’s Accu-Chek SmartGuide continuous glucose monitoring sensor.

What’s next

The health tech sector anticipates further developments in AI implementation, regulatory oversight, and digital health expansion as these initiatives progress.